Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered excitatory amino acid receptor antagonists

Pain

Volumn 66, Issue 2-3, 1996, Pages 279-285

  Jing Xia, Hao ^a   Xiao Jun, Xu ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allodynia; Analgesia; Central pain; Chronic pain; Dextromethorphan; Excitatory amino acids; Neuropathic pain; NMDA antagonist; Spinal cord injury

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMINO ACID RECEPTOR BLOCKING AGENT; DEXTROMETHORPHAN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

EID: 0030220802     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03019-9     Document Type: Article

References (39)

1. Aanonsen L.M., Lei S., Wilcox L.M. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1990;309-321.
2. Backonja M., Arndt G., Gombar K.A., Check B., Zimmermann M. Response of chronic neuropathic pain syndrome to ketamine: a preliminary study. Pain. 56:1994;51-58.
3. Bem J.L., Peck R. Dextromethorphan: an overview of safety issues. Drug Safety. 7:1992;7190-7199.
4. Benson W.M., Stefko P.L., Randall L.O. Comparative pharmacology of levorphanol, racemorphan and dextrorphan and related methyl ethers. J. Pharmacol. Exp. Ther. 109:1953;189-200.
5. Casey, K.L., Pain and central nervous system disease: a summary and overview. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: The Central Pain Syndromes. Raven Press, New York, 1991, pp. 1-11.
6. Choi D.W., Peters S., Visekul V. Dextrorphan and levorphanol selectively block N-methyl- D-aspartate receptor-mediated neurotoxicity on cortical neurons. J. Pharmacol. Exp. Ther. 242:1987;713-720.
7. Church J. Neuromodulatory effects of dextromethorphan: role of NMDA receptors in responses. Trends Pharmacol. Sci. 11:1990;146-147.
8. Church J., Lodge D., Berry S.C. Differential effects of dexthorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur. J. Pharmacol. 111:1985;185-190.
9. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
10. Dickenson A.H., Sullivan A.F., Stanfa L.C., McQuay H.J. Dextromethorphan and levorphanol on dorsal horn nociceptive neurones in the rat. Neuropharmacology. 30:1991;1303-1308.
11. Eaton S.A., Salt T.E. Membrane and action potential responses evoked by excitatory amino acids acting at N-methyl- D-aspartate receptors in the rat thalamus in vivo. Neuroscience. 44:1991;277-286.
12. Elliott K., Hynansky A., Inturrisi C.E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain. 59:1994;361-368.
13. Gale K., Kerasidis H., Wrathall J.R. Spinal cord contusion in the rat: Behavioral analysis of functional neurological impairments. Exp. Neurol. 88:1985;123-134.
14. Hao J.-X., Xu X.-J., Aldskogius H., Seiger Å., Wiesenfeld-Hallin Z. Allodynia-like effect in rat after ischemic spinal cord injury photochemically induced by laser irradiation. Pain. 45:1991;175-185.
15. Jeanmond D., Magnin M., Morel A. Thalamus and neurogenic pain: physiological, anatomical and clinical data. Neuroreport. 4:1993;475-478.
16. Koyama S., Katayama Y., Maejima S., Hirayasu T., Fujii M., Tsubokawa T. Thalamic neuronal hyperactivity following transection of the spinothalamic tract in the cat: involvement of N-methyl- D-aspartate receptor. Brain Res. 612:1992;345-350.
17. Kristensen J.D., Svensson B., Gordh T. Jr. The NMDA-receptor antagonist CPP abolishes neurogenic `wind-up pain' after intrathecal administration in humans. Pain. 51:1992;249-253.
18. Lehmann J., Hutchison A.J., McPherson S.E., Mondadori C., Schmutz M., Sinton C.M., Tsai C., Murphy D.E., Steel D.J., Williams M., Cheney D.L., Wood P.L. CGS 19755, a selective and competitive N-methyl- D-aspartate-type excitatory amino acid receptor antagonist. J. Pharmacol. Exp. Ther. 246:1988;65-75.
19. Leijon, G. and Boivie, J., Pharmacological treatment of central pain. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: The Central Pain Syndromes. Raven Press, New York, 1991, pp. 257-266.
20. Lenz, F., The thalamus and central pain syndromes: human and animals studies. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: The Central Pain Syndromes. Raven Press, New York, 1991, pp. 171-182.
21. Lipton S.A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16:1993;527-533.
22. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
23. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J., Frank H. Intrathecal dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res. 605:1993;164-168.
24. McQuay H.J., Carroll D., Jadad A.R., Glynn C.J.H., Jack T., Moore R.A., Wiffen P.J. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain. 59:1994;127-133.
25. 2α injected into conscious mice. Pain. 57:1994;225-231.
26. Pagni, C.A., Central pain due to spinal cord and brain stem damage. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain. Churchill Livingstone, London, 1989, pp. 634-655.
27. Ren K., Hylden J.L.K., Williams G.M., Ruda M.A., Dubner R. The effects of non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 50:1992;331-344.
28. Rupniak N.M.J., Boyce S., Tye S., Cook G., Iversen S.D. Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates. Pharmacol. Biochem. Behav. 44:1993;153-156.
29. Salt T.E., Eaton S.A. Function of non-NMDA receptors and NMDA receptors in synaptic responses to natural somatosensory stimulation in the ventrobasal thalamus. Exp. Brain Res. 77:1989;646-652.
30. Sunderland, S., Nerves and Nerve Injuries, Churchill Livingstone, Edinburgh, 1978.
31. Tal M., Bennett G.J. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci. Lett. 151:1993;107-110.
32. Tasker, R.R., Pain resulting from central nervous system pathology (central pain). In: J.J. Bonica (Ed.), The Management of Pain. Lea and Febiger, Philadelphia, PA, 1990, pp. 264-283.
33. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:1989;127-135.
34. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl- D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
35. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl- D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-300.
36. Xu X.-J., Hao J.-X., Aldskogius H., Seiger Å., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290.
37. Xu X.-J., Hao J.-X., Arnér S., Lindblom U., Seiger Å., Wiesenfeld-Hallin Z. Systemic mexiletine relieves the chronic allodynia-like symptoms in spinally injured rats. Anesth. Analg. 74:1992;648-652.
38. Xu X.-J., Hao J.-X., Seiger Å., Hughes J., Hökfelt T., Wiesenfeld-Hallin Z. Chronic pain-related behaviours in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain. 56:1994;271-277.
39. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperalgesia induced by constriction injury of sciatic nerve. II. Excitatory amino acid antagonists. Pain. 49:1992;121-128.